ACLX
Price
$69.57
Change
-$0.68 (-0.97%)
Updated
Aug 29, 03:45 PM (EDT)
Capitalization
3.9B
80 days until earnings call
MLYS
Price
$15.39
Change
+$0.17 (+1.12%)
Updated
Aug 29, 04:09 PM (EDT)
Capitalization
1.01B
74 days until earnings call
Interact to see
Advertisement

ACLX vs MLYS

Header iconACLX vs MLYS Comparison
Open Charts ACLX vs MLYSBanner chart's image
Arcellx
Price$69.57
Change-$0.68 (-0.97%)
Volume$400
Capitalization3.9B
Mineralys Therapeutics
Price$15.39
Change+$0.17 (+1.12%)
Volume$300
Capitalization1.01B
ACLX vs MLYS Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. MLYS commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and MLYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ACLX: $70.25 vs. MLYS: $15.22)
Brand notoriety: ACLX and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 441% vs. MLYS: 93%
Market capitalization -- ACLX: $3.9B vs. MLYS: $1.01B
ACLX [@Biotechnology] is valued at $3.9B. MLYS’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 1 green, 4 red.
According to our system of comparison, MLYS is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while MLYS’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • MLYS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -2.12% price change this week, while MLYS (@Biotechnology) price change was +4.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

MLYS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.9B) has a higher market cap than MLYS($1.01B). MLYS YTD gains are higher at: 23.639 vs. ACLX (-8.397). ACLX has higher annual earnings (EBITDA): -179.78M vs. MLYS (-203.01M). ACLX has more cash in the bank: 453M vs. MLYS (325M). ACLX has higher revenues than MLYS: ACLX (57M) vs MLYS (0).
ACLXMLYSACLX / MLYS
Capitalization3.9B1.01B386%
EBITDA-179.78M-203.01M89%
Gain YTD-8.39723.639-36%
P/E RatioN/AN/A-
Revenue57M0-
Total Cash453M325M139%
Total Debt52.5MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACLXMLYS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
87%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 26 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNACX126.751.18
+0.94%
Harbor Capital Appreciation Retirement
ODMCX11.19N/A
N/A
JPMorgan SMID Cap Equity C
SIBLX29.99N/A
N/A
Touchstone Balanced Y
TIAGX13.64N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl I
ACFLX11.30N/A
N/A
American Century Focused Lg Cap Val G

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.50%
CGON - ACLX
57%
Loosely correlated
+0.89%
RNA - ACLX
55%
Loosely correlated
+1.59%
ROIV - ACLX
54%
Loosely correlated
-0.42%
XNCR - ACLX
52%
Loosely correlated
+0.37%
CRNX - ACLX
52%
Loosely correlated
+0.82%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+0.07%
PTGX - MLYS
52%
Loosely correlated
-5.36%
BIESF - MLYS
45%
Loosely correlated
N/A
CRNX - MLYS
36%
Loosely correlated
+0.82%
ACLX - MLYS
36%
Loosely correlated
+0.50%
APGE - MLYS
36%
Loosely correlated
-3.10%
More